BOLT vs FAST · rev $7.7M vs P/E 43, rev $7.55B
Bolt Biotherapeutics (BOLT) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
BOLT currently screens at market cap $11.3M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the BOLT and FAST stock pages for the full models.
Not investment advice.